Value of the intraoperative assessment of the depth of myometrial invasion in endometrial carcinoma

Ginekologia Polska

Volumn 79, Issue 6, 2008, Pages 404-409

  Obrzut, Bogdan ^a,b   Obrzut, Marzanna ^a,b   Skret Magierło, Joanna ^a   Skret, Andrzej ^a,b   Ulman, Dariusz ^a   Król, Piotr ^c   Zmuda, Marcin ^b  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b The F Chopin Provincial Specialised Hospital   (Poland)

^c RZESZOW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Endometrial carcinoma; Myometrium invasion

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; MIDDLE AGED; MYOMETRIUM; PATHOLOGY; POLAND; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLAND; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 48849112775     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DiSaia P, Creasman W. Ginekologia onkologiczna. Tom I. Lublin: Czelej, 1999, 169-208.
2. Greenlee R, Murray T, Bolden S, [et al.]. Cancer statistics, 2000. CA Cancer J Clin. 2000, 50, 7-33.
3. Horn L. Das Endometriumkarzinom - von der molekularen Pathogenese über die Histomorphologie zur individualisierten Therapie. Zentralbl Gynäkol. 2002, 1, 1-2.
4. Vizza E, Galati G, Corrado G, [et al.]. Role of pelvic lymphadenectomy in the management of stage I endometrial cancer: our experience. Eur J Gynaecol Oncol. 2003, 24, 126-128.
5. Emerich J. Leczenie raka błony śluzowej trzonu macicy. W: Rak błony śluzowej trzonu macicy. Red. Markowska J. Warszawa: Springer PWN, 1998, 153-164.
6. Kurzgefasste interdisziplinare AGO-Leitlinien für die Diagnostik und Therapie des Endometriumskarzinoms. Zentralbl Gynäkol. 2002, 1, 58-62.
7. Zieliński J. Nowotwory kobiecego narzadu płciowego. W: Zasady rozpoznawania i leczenia nowotworów zalecane przez Centrum Onkologii w Warszawie. Red. Kułakowski A, Towpik E. Warszawa: Wydawnictwo Polskiej Fundacji Europejskiej Szkoły Onkologii, 1997, 41-65.
8. Tropé C, Alektiar K, Sabbatini P, [et al.]. Corpus: Epithelial Tumors. W: Principles and practice of gynecologic oncology. Ed. Hoskins W, Perez C, Young R, [et al]. Philadelphia: Lippincott Williams & Wilkins, 2005, 823-872.
9. Baker T. Rak endometrium. W: Podrecznik onkologii ginekologicznej. Red. Piver M. Warszawa: PZWL, 1999, 197-222.
10. Dreher E, Hänggi W. Basisrichtlinien zur Behandlung des Korpuskarzinoms. Arch Gynecol Obstet. 1991, 249, 95-98.
11. Łapińska-Szumczyk S, Emerich J. Kliniczna wartość usuwania wezłów chłonnych miednicy mniejszej w leczeniu operacyjnym raka błony śluzowej trzonu macicy. Ginekol Pol. 2002, 73, 976-979.
12. DelMaschio A, Vanzulli A, Sironi S, [et al.]. Estimating the depth of myometrial involvement by endometrial carcinoma: Efficacy of transvginal sonography vs MR imaging. Am J Roentgenol. 1993, 160, 533-538.
13. Gordon A, Fleischer A, Dudley B. Preoperative assessment of myometrial invasion of endometrial adenocarcinoma by sonography (US) and magnetic resonance imaging (MRI). Gynecol Oncol. 1989, 34, 175-179.
14. Prömpeler H, Madjar H, du Bois A, [et al.]. Transvaginal sonography of myometrial invasion depth in endometrial cancer. Acta Obstet Gynecol Scand. 1994, 73, 343-346.
15. Kolben M, Höss C, Oberlechner E, [et al.]. Operative Therapie des Endometriumskarzinoms. In: Manual Malignome des Corpus uteri. 3th.Ed. Dannecke C, Kolben M, Kürzl R. München: Zuckschwerdt GmbH Verlag, 2007, 28-35.
16. Cunha T, Felix A, Cabral I. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: Comparison of magnetic resonance imaging and gross visual inspection. Int J Gynecol Cancer. 2001, 11, 130-136.
17. Baltzer J, Meerphol H, Bahnsen J. Praxis der gynäkologischen Onkologie. 2th. Stuttgart-New York: Georg Thieme Verlag, 2000, 200-220
18. Bidziński M, Dańska-Bidzińska A, Derlatka P [et al.]. Ocena ryzyka nawrotu nowotworu u chorych leczonych z powodu raka błony śluzowej trzonu macicy w stopniu I wg klasyfikacji klinicznej FIGO. Ginekol Pol. 2007, 78, 471-475.
19. FIGO. Changes in gynecologic staging by the International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol. 1990, 162, 610-611.
20. Morrow C, Bundy B, Kurman R. Relationship between surgical-pathological risk factor sand outcome in clinical stage I and II carcinoma of the endometrium. A Gynaecologic Oncology Group Study. Gynecol Oncol. 1991, 2, 55-65.
21. Creasman W, Morrow C, Bundy B, [et al.]. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987, 60, 2035-2041.
22. Sehouli J, Lichtenegger W. Management des Endometriumkarzinoms Standards und neue Trends. Gynäkologe. 2004, 37, 245-25.
23. Kürzl R. Prätherapeutische Diagnostik. In: Manual Malignome des Corpus uteri. 3th. Ed Dannecker C, Kolben M, Kürzl R. München: Zuckschwerdt GmbH Verlag, 2007,11-15
24. Randelzhofer B, Pohle M, Latterman U, [et al.]. Sonographische Bestimmung der Infiltrationstiefe beim Endometriumkarzinom. Geburtsh Frauenheilk. 1999, 59, 167-170.
25. Dore R, Moro G, D'Andrea F, [et al.]. CT evaluation of myometrium invasion in endometrial carcinoma. J Comput Assist Tomogr. 1987, 11, 282-289.
26. Hamm B, Pöllinger A. Radiologische Schnittbilddiagnostik beim Endometriumkarzinom. Zentralbl Gynäkol. 2002, 124, 27-31.
27. Yamashita Y, Harada M, Sawada T, [et al.]. Normal uterus and FIGO stage I endometrial carcinoma: Dynamic gadolinium-enhanced MR imaging. Radiology. 1993, 186, 495-501.
28. Yazigi R, Cohen J, Munoz A, [et al.]. Magnetic resonance imaging determination of myometrial invasion in endometrial cancer. Gynecol Oncol. 1989, 34, 94-97.
29. Kim S, Kim H, Song Y, [et al.]. Detection of deep myometrial invasion in endometrial carcinoma: Comparison of transvaginal ultrasound, CT and MRI. J Comput Assist Tomogr. 1995, 19, 766-772.
30. Frei K, Kinkel K, Bonel H, [et al.]. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrastenhances MR imaging-a meta-analysis and Bayesian analysis. Radiology. 2000, 216, 444-449.
31. Vorgias G, Hintipas E, Katsoulis N, [et al.]. Intraoperative gross examination of myometrial invasion and cervical infiltration in patients with endometrial cancer: decision-making accuracy. Gynecol Oncol. 2002, 85, 483-486.
32. Franchi M, Ghezzi F, Melpignano M, [et al.]. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol. 2000, 76, 357-361.
33. Doering D, Barnhill D, Weiser E, [et al.]. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial carcinoma. Obstet Gynecol. 1989, 74, 930-933.
34. Goff B, Rice L. Assesment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990, 38, 46-48.
35. Fanning J, Tsukada Y, Piver M. Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990, 37, 47-50.